Bibliography （英文論文） 1998年

1. Suto R, Abe Y, Nakamura M, Ohnishi Y, Yoshimura M, Lee YH, Imanishi T, Yamazaki H, Kijima H, Tokunaga T, Oshika Y, Hiraoka N, Tamaoki N, Fukuda H, Ueyama Y. Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo. Int J Oncol. 1998; 12: 287-291.
2. Oshika Y, Nakamura M, Hatanaka H, Abe Y, Tokunaga T, Ohnishi Y, Kijima H, Yamazaki H, Tamaoki N, Ueyama Y. A human lung cancer xenograft producing granulocyte-colony stimulating factor and parathyroid hormone-related protein. Oncol Reports. 1998; 5: 359-362.
3. Kuwabara A, Watanabe H, Ajioka Y, Yasuda K, Saito H, Matsuda K, Kijima H, Hatakeyama K. Alteration of p53 clonarity accompanying colorectal cancer progression. Jpn J Cancer Res. 1998; 89: 40-46.
4. Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N, Nakamura M. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer. 1998; 77: 998-1002.
5. Oshika Y, Nakamura M, Tokunaga T, Ozeki Y, Fukushima Y, Hatanaka H, Abe Y, Yamazaki H, Kijima H, Tamaoki N, Ueyama Y. Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small lung cancer. Int J Oncol. 1998; 12: 541-544.
6. Matsubayashi H, Watanabe H, Nishikura K, Ajioka Y, Kijima H, Saito T. Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation. Cancer. 1998; 82: 651-660.
7. Yamazaki H, Kijima H, Ohnishi Y, Abe Y, Oshika Y, Tsuchida T, Tokunaga T, Tsugu A, Ueyama Y, Tamaoki N, Nakamura M. Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression. J Natl Cancer Inst. 1998; 90: 581-587.
8. Yasuda S, Shohtsu A, Ide M, Takagi S, Kijima H, Horiuchi M. Evaluated F-18 FDG Uptake in plasmacyte-rich chronic maxillary sinusitis. Clin Nucl Med. 1998; 23: 176-178.
9. Kijima H, Bouffard DY, Scanlon KJ. Ribozymes as a novel approach for the treatment of human pancreatic carcinoma. Method Mol Med. 1998; 11: 193-208.
10. Iwasaki M, Ogawa J, Inoue H, Kijima H, Watanabe K. Immunohistochemical properties of lipid peroxidation and prognosis in adenocarcinoma of the lung. J Cardiovasc Surg. 1998; 39: 233-236.
11. Terasaki Y, Sato S, Yoshida H, Iezumi K, Suto A, Takeshita T, Omiya H, Kijima H. Breast invasive lobular carcinoma mimicking medullary carcinoma. Acta Cytologica 1998; 42, 812-815.
12. Kijima H, Tsuchida T, Kondo H, Iida T, Oshika Y, Nakamura M, Scanlon KJ, Kondo T, Tamaoki N. Hammerhead ribozymes against γ-glutamylcysteine synthetase mRNA down-regulate intracellular glutathione concentration of mouse islet cells. Biochem Biophys Res Commun. 1998; 247: 697-703.
13. Tokunaga T, Kijima H, Oshika Y, Fukushima Y, Abe Y, Ohnishi Y, Yamazaki H, Tsuchida T, Makuuchi H, Tamaoki N, Ueyama Y, Nakamura M. Aberrant isoform of vascular endothelial growth factor 189 expression is correlated with xenotransplantability of human esophageal cancer. Oncol Reports. 1998; 5: 1115-1118.
14. Fukushima Y, Oshika Y, Nakamura M, Tokunaga T, Hatanaka H, Abe Y, Yamazaki H, Kijima H, Ueyama Y, Tamaoki N. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells. Int J Mol Med. 1998; 2: 349-351.
15. Oshika Y, Masuda K, Tokunaga T, Hatanaka H, Kamiya T, Abe Y, Ozeki Y, Kijima H, Yamazaki H, Tamaoki N, Ueyama Y, Nakamura M. Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer. Clin Cancer Res. 1998; 4: 1785-1788.
16. Kijima H, Scanlon KJ. Therapeutic application of an anti-ras ribozyme in human pancreatic cancer. In: Scanlon KJ, Kashani-Sabet M, eds. Ribozymes in Gene Therapy of Cancer -, Medical Intelligence Unit. Georgetown, TX: P.G. Landes; 1998: 143-150.
17. Matsubayashi H, Watabane H, Nishikura K, Ajioka Y, Maejima T, Kijima H, Saitoh T. Advantages of immunostaining over DNA analysis using PCR amplification to detect p53 abnormality in long-term formalin-fixed tissues of human colorectal carcinomas. J Gastroenterol. 1998; 33: 662-669.
18. Fukushima Y, Oshika Y, Tsuchida T, Tokunaga T, Hatanaka H, Kijima H, Yamazaki H, Ueyama Y, Tamaoki N, Nakamura M. Brain-specific angiogenesis inhibitor 1 expression is inversely correlated with vascularity and distant metastasis of colorectal cancer. Int J Oncol. 1998; 13: 967-970.
19. Tokunaga T, Nakamura M, Oshika Y, Tsuchida T, Kazuno M, Fukushima Y, Kawai K, Abe Y, Kijima H, Yamazaki H, Tamaoki N, Ueyama Y. Alterations in tumour suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells. Virchows Arch. 1998; 433: 415-418.
20. Oshika Y, Nakamura M, Abe Y, Fukuchi Y, Yoshimura M, Itoh M, Ohnishi Y, Tokunaga T, Fukushima Y, Hatanaka H, Kijima H, Yamazaki H, Tamaoki N, Ueyama Y. Growth stimulation of non-small cell lung cancer xenografts by granulocyte-macrophage colony-stimulating factor (GM-CSF). Eur J Cancer. 1998; 34: 1958-1961.
21. Yoshida H, Kijima H, Terasaki Y, Suto A, Takeshita T, Omiya H, Shimojima K, Shimbori M, Sato T, Sato S, Onoda N, Yamazaki H, Tamaoki N, Ueyama Y, Nakamura M. Heterogeneous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer. Int J Oncol. 1998; 13: 1141-1146.
22. Tsuchida T, Kijima H, Oshika Y, Tokunaga T, Yamazaki H, Nakamura M, Tamaoki N, Scanlon KJ, Ueyama Y. A hammerhead ribozyme specifically inhibits mutant K-ras mRNA of human pancreatic cancer cells. Biochem Biophys Res Commun. 1998; 253: 368-373.
23. Sato T, Sato S, Yoshida H, Terasaki Y, Okamoto H, Hanada N, Kanabuchi K, Kijima H. Diffuse large B-cell lymphoma with sclerosis of the thymus. Acta Cytologica. 1998; 42: 1492-1494.
24. Yamazaki H, Abe Y, Katoh Y, Sawa N, Ohnishi Y, Tanaka Y, Sasano H, Oshika Y, Tokunaga T, Kijima H, Tamaoki N, Nakamura M, Ueyama Y. Establishment of an adrenocortical carcinoma xenograft with normotensive hyperaldosteronism in vivo. APMIS. 1998; 106: 1056-1060.